Literature DB >> 22508714

Gender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men.

Ivana Sarac1, Katharine Backhouse, Fariba Shojaee-Moradie, Michael Stolinski, M Denise Robertson, Jimmy D Bell, E Louise Thomas, Roman Hovorka, John Wright, A Margot Umpleby.   

Abstract

CONTEXT: High plasma triglycerides (TG) have been shown to be independent and better predictors of cardiovascular disease than low-density lipoprotein (LDL) cholesterol in women. This may be due to gender differences in very-low-density lipoprotein 1 (VLDL(1))- and VLDL(2)-TG and fatty acid kinetics.
OBJECTIVE: Our objective was to investigate whether there are differences in VLDL(1)- and VLDL(2)-TG and fatty acid kinetics in obese men and postmenopausal women, a high risk group for cardiovascular disease. RESEARCH DESIGN AND METHODS: Stable isotopes techniques were used to measure fasting palmitate rate of appearance, metabolic clearance rate, oxidation rate, and nonoxidative disposal rate, VLDL(1)-TG and VLDL(2)-TG fractional catabolic rate (FCR) and production rate (PR). Whole-body fat distribution was measured by magnetic resonance imaging. PARTICIPANTS: Participants included 10 postmenopausal obese women and eight obese men matched for age, body mass index, and fasting plasma TG.
RESULTS: The women had lower visceral fat and higher sc fat than the men (P < 0.001 and P < 0.002). Palmitate rate of appearance, metabolic clearance rate, nonoxidative disposal rate, and oxidation rate corrected for resting energy expenditure were greater in the women than the men (all P < 0.03). VLDL(2)-TG PR corrected for fat-free mass was higher in the women (P < 0.001). VLDL(2)-TG and VLDL(2)-cholesterol pools were higher in the women (P < 0.001 and P < 0.008). VLDL(1)-TG FCR and PR and VLDL(2)-TG FCR were not different between genders.
CONCLUSION: Fatty acid and VLDL(2)-TG flux is higher in postmenopausal obese women than in obese men matched for fasting plasma TG levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508714     DOI: 10.1210/jc.2011-3248

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease.

Authors:  E Cure; A Icli; A Ugur Uslu; R Aydoğan Baykara; D Sakiz; M Ozucan; F Yavuz; S Arslan; M Cumhur Cure; A Kucuk
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

2.  Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss.

Authors:  Aaron Jesuthasan; Sviatlana Zhyzhneuskaya; Carl Peters; Alison C Barnes; Kieren G Hollingsworth; Naveed Sattar; Michael E J Lean; Roy Taylor; Ahmad H Al-Mrabeh
Journal:  Diabetologia       Date:  2021-10-16       Impact factor: 10.122

3.  Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.

Authors:  Camilla Pramfalk; Michael Pavlides; Rajarshi Banerjee; Catriona A McNeil; Stefan Neubauer; Fredrik Karpe; Leanne Hodson
Journal:  J Clin Endocrinol Metab       Date:  2015-09-28       Impact factor: 5.958

4.  Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins.

Authors:  Motoki Yamashita; Atsushi Iwata; Yuta Kato; Makito Futami; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Journal:  Heart Vessels       Date:  2018-04-25       Impact factor: 2.037

5.  Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women.

Authors:  Leanne Hodson; Rajarshi Banerjee; Belén Rial; Wiebke Arlt; Martin Adiels; Jan Boren; Kyriakoula Marinou; Ciaran Fisher; Ingrid L Mostad; Irene M Stratton; P Hugh R Barrett; Dick C Chan; Gerald F Watts; Karin Harnden; Fredrik Karpe; Barbara A Fielding
Journal:  J Am Heart Assoc       Date:  2015-10-02       Impact factor: 5.501

6.  Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets.

Authors:  A Margot Umpleby; Fariba Shojaee-Moradie; Barbara Fielding; Xuefei Li; Andrea Marino; Najlaa Alsini; Cheryl Isherwood; Nicola Jackson; Aryati Ahmad; Michael Stolinski; Julie A Lovegrove; Sigurd Johnsen; A S Jeewaka R Mendis; John Wright; Malgorzata E Wilinska; Roman Hovorka; Jimmy D Bell; E Louise Thomas; Gary S Frost; Bruce A Griffin
Journal:  Clin Sci (Lond)       Date:  2017-10-17       Impact factor: 6.124

7.  Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.

Authors:  Charlotte J Green; Thomas Marjot; John Walsby-Tickle; Catriona Charlton; Thomas Cornfield; Felix Westcott; Katherine E Pinnick; Ahmad Moolla; Jonathan M Hazlehurst; James McCullagh; Jeremy W Tomlinson; Leanne Hodson
Journal:  Eur J Endocrinol       Date:  2022-02-07       Impact factor: 6.664

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.